Export 7 results:
Author Title Type [ Year(Desc)]
Filters: Author is Nunes, Edward V  [Clear All Filters]
2012
A. N. C. Campbell, Nunes, E. V., Miele, G. M., Matthews, A., Polsky, D., Ghitza, U. E., Turrigiano, E., Bailey, G. L., VanVeldhuisen, P., Chapdelaine, R., Froias, A., Stitzer, M. L., Carroll, K. M., Winhusen, T., Clingerman, S., Perez, L., McClure, E., Goldman, B., and A Crowell, R., “Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.”, Contemp Clin Trials, vol. 33, no. 2, pp. 386-95, 2012.
A. N. C. Campbell, Miele, G. M., Nunes, E. V., McCrimmon, S., and Ghitza, U. E., “Web-based, psychosocial treatment for substance use disorders in community treatment settings.”, Psychol Serv, vol. 9, no. 2, pp. 212-4, 2012.
2014
A. N. C. Campbell, Nunes, E. V., Matthews, A. G., Stitzer, M., Miele, G. M., Polsky, D., Turrigiano, E., Walters, S., McClure, E. A., Kyle, T. L., Wahle, A., Van Veldhuisen, P., Goldman, B., Babcock, D., Stabile, P. Quinn, Winhusen, T., and Ghitza, U. E., “Internet-delivered treatment for substance abuse: a multisite randomized controlled trial.”, Am J Psychiatry, vol. 171, no. 6, pp. 683-90, 2014.
2016
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., “NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.”, Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
2018
J. D. Lee, Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., King, J., Lindblad, R., Liu, D., Matthews, A. G., May, J., K Peavy, M., Ross, S., Salazar, D., Schkolnik, P., Shmueli-Blumberg, D., Stablein, D., Subramaniam, G., and Rotrosen, J., “Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.”, Lancet, vol. 391, no. 10118, pp. 309-318, 2018.
2021
M. H. Trivedi, Walker, R., Ling, W., Cruz, A. Dela, Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., Sparenborg, S., Coffin, P., Schmitz, J., Wiest, K., Bart, G., Sonne, S. C., Wakhlu, S., A Rush, J., Nunes, E. V., and Shoptaw, S., “Bupropion and Naltrexone in Methamphetamine Use Disorder”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
2023
M. G. Greiner, Shulman, M., Opara, O., Potter, K., Voronca, D. C., Tafessu, H. M., Hefner, K., Hamilton, A., Scheele, C., Ho, R., Dresser, L., Jelstrom, E., Fishman, M., Ghitza, U. E., Rotrosen, J., Nunes, E. V., and Bisaga, A., “Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A Stepped Wedge Hybrid Type 1 Effectiveness-Implementation Study”, Contemp Clin Trials, vol. 128, p. 107148, 2023.